A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian Cancer

Evaluation Compared with traditional NACT, whether PIPAC can increase the incidence of CRS3 determines the rationality of choosing PIPAC.

Trial Details

NCT ID
NCT07544030
Phase
PHASE3
Sponsor
tongweihua
Status
RECRUITING
Cancer Type
High-Grade Serous Ovarian Cancer
Interventions
  • PIPAC
Locations (sample)
  • Changchun, Jilin, China|43.88,125.32278

Key Eligibility Criteria

  • Patients with high-grade serous adenocarcinoma (HGSOC) with FIGO stage IIIC-IVA.
  • Age between 18 and 70.
  • Patients were evaluated with Fagotti score and MD Anderson score. MD Anderson score was consistent with Fagotti score ≥ 8, which was evaluated as h…
  • Normal renal function (blood creatinine: 58-96 μmol/L).

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find High-Grade Serous Ovarian Cancer Trials on Trialify →